1,853 material Form 8-K filings that 1,500 companies we cover made with the SEC in September 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Caring Brands, Inc. appointed Brian R. Meadows as an independent director, effective September 4, 2026. Meadows is president of Myall Luna Ventures Inc., which the company also engaged under a consulting agreement to provide financial and accounting management services for a term running from September 2, 2026 through September 1, 2027. The board considered that consulting relationship when it determined Meadows was independent, which shareholders may weigh when assessing board independence.
Consulting fee of $10,000 per month, payable in advance, with either party able to terminate on at least 30 days' written notice
Director Agreement provides an annual grant of options to purchase 25,000 shares of common stock at market price, expiring five years after issuance
Meadows has served as Chief Financial Officer of Jones Soda Co. since 2025
Board approved the appointment on September 3, 2026, after nominating committee approval on August 28, 2026
Whitehawk Therapeutics increased its board from nine to ten directors and appointed Vijay Iyengar, M.D., as a Class III director effective September 9, 2026. Dr. Iyengar previously served as Executive Vice President at Incyte Corporation until November 2025, and the filing describes his oncology and life sciences experience as the basis for his appointment.
Board size increased from nine to ten; Dr. Iyengar's term expires at the 2029 annual meeting
Non-employee director base annual retainer of $40,000 under the Outside Director Compensation Policy
Initial stock option grant of 76,080 shares, vesting monthly over three years
Served as Executive Vice President at Incyte Corporation from May 2022 to November 2025
Ameresco's board named two finance vice presidents to serve as interim principal financial officer and interim principal accounting officer while the company searches for a new chief financial officer. CFO Mark Chiplock, who resigned as previously disclosed in an August 19, 2026 filing, leaves the role effective September 25, 2026.
Julie Bradshaw, Vice President, Finance, designated interim principal financial officer on September 8, 2026
Debbie Angelico, Vice President, Finance, designated interim principal accounting officer on September 8, 2026
Mark Chiplock's resignation as CFO and principal financial and accounting officer is effective September 25, 2026
The company has commenced a search for a new Chief Financial Officer
Kadant's board adopted a succession plan under which Michael C. Colwell becomes president and chief operating officer on October 1, 2026, and president and chief executive officer on January 2, 2027, when Jeffrey L. Powell becomes executive chairman. Chairman Jonathan W. Painter will leave the board on January 2, 2027. The filing contains no financial results, and the changes are a planned leadership transition for shareholders to track.
Michael C. Colwell, 60, is senior vice president responsible for the Industrial Processing segment and will join the board on January 2, 2027.
Jeffrey L. Powell remains president through September 30, 2026, and CEO through January 2, 2027, then becomes executive chairman and retires January 1, 2028.
Powell's annualized base salary will be $998,900 through January 2, 2027, and $499,450 after that, under a Transition and Executive Chairman Agreement.
Jonathan W. Painter, current chairman, will cease to serve as a director on January 2, 2027; he stated his resignation did not result from any disagreement with the Company.
TransMedics appointed Fernando Araujo, most recently CFO of GE HealthCare's Advanced Imaging Solutions segment, as Chief Financial Officer and Treasurer effective September 21, 2026, succeeding Gerardo Hernandez, who will move to a non-executive role and then a senior advisor position focused on Latin America. In the same announcement, the company reiterated its 2026 revenue guidance of $737 million to $757 million, which excludes PAD Aviation and will be revisited with third quarter results. The filing reports no change to financial results or guidance, but the change in finance leadership is a notable item for shareholders.
Fernando Araujo, age 46, becomes CFO and Treasurer effective September 21, 2026, with a $590,000 base salary and a 60% target bonus
Araujo receives a $200,000 cash sign-on bonus plus initial stock option and RSU awards each with a grant date value of approximately $1.75 million
Gerardo Hernandez remains a non-executive employee through December 31, 2026, then serves as a non-employee senior advisor until April 30, 2027
2026 revenue guidance of $737 million to $757 million was reiterated; the company will revisit it with third quarter 2026 results
Fortive's board increased its size from eight to nine members effective September 9, 2026, and appointed Susan L. Main as a director with a term running to the 2027 annual shareholder meeting. The board also named her to the Audit Committee and determined she is independent under NYSE standards and an audit committee financial expert.
Susan L. Main appointed to the board effective September 9, 2026; board size raised from eight to nine
Ms. Main also appointed to the Audit Committee of the Board
Board determined Ms. Main is independent under NYSE listing standards and an audit committee financial expert
Her non-employee director compensation matches that of other non-employee directors, per the Form 10-Q for the quarter ended July 3, 2026
Reborn Coffee's board increased its size from seven to eight members on September 3, 2026, and appointed James Lim and Edward Park to fill the vacancies. The filing says neither director will receive compensation for board service, neither has been placed on a committee, and neither has a reportable related party transaction.
Board increased from seven to eight members on September 3, 2026
James Lim and Edward Park appointed as directors on September 3, 2026
Neither director will receive compensation or serve on a board committee, per the filing
Directors serve until the next annual stockholder meeting
DexCom appointed Glenn S. Boehnlein as a director effective September 10, 2026, increasing the board to thirteen members. He joins the Audit Committee and the Operations & Innovation Committee, and the filing describes him as independent under Nasdaq listing standards.
Boehnlein most recently served as Vice President and Chief Financial Officer of Stryker Corporation from 2016 to 2025.
Initial equity grant of restricted stock units with a fair value of $500,000, vesting annually over three years.
Annual director equity grant expected around the 2027 Annual Meeting with a fair value of $347,500.
Term expires at the 2027 annual meeting of stockholders.
Matador Resources said co-president Van H. Singleton, II retired from his role as Co-President of land, acquisitions and divestitures and planning on September 9, 2026, and moved to a Special Advisor role to the Board and Executive Committee. Bryan A. Erman, already Co-President, Chief Legal Officer and Head of M&A, takes over Singleton's co-presidency, and Jonathan J. Filbert takes over his land and acquisition and divestiture responsibilities.
Van H. Singleton, II retired as Co-President on September 9, 2026 and became Special Advisor to the Board and Executive Committee.
Bryan A. Erman, Co-President since June 2025, assumes Singleton's co-president role.
Jonathan J. Filbert, Executive Vice President – Land since October 2023, takes over land and acquisition and divestiture efforts.
Singleton's advisor agreement provides an annual fee of $450,000 paid monthly and continued vesting of his outstanding equity awards.
Park Hotels & Resorts approved one-time retention restricted stock awards to four executive officers on September 3, 2026, including 331,564 shares to CEO Thomas J. Baltimore, Jr. The awards vest in full on the fourth anniversary of the grant date, subject to continued employment, and are intended to address leadership transition and recruiting risks. The grants add to the share count tied to executive pay, and their vesting terms determine how much stock is retained if an executive leaves.
September 3, 2026: Compensation & Human Capital Committee approved one-time Retention RSA Awards
Carlisle Companies announced that director Jesse G. Singh resigned from its board on September 10, 2026, citing a change in his employment, and not any disagreement with the company. The board also fixed its size at six directors, and the company thanked Singh for more than eight years of service.
Jesse G. Singh resigned as a director effective at the conclusion of the September 10, 2026 board meeting.
Resignation was due to a change in his employment, per the company's governance guidelines; the filing states no disagreement with the company.
The board fixed the number of directors at six following the resignation.
AptarGroup's Chief Accounting Officer, Aditya Gandhi, resigned effective September 11, 2026, to pursue another opportunity outside the greater Chicago area, and the company said the decision was not related to any disagreement on operations, policies or practices. The Board appointed Daniel Ackerman, a former CAO, as interim Chief Accounting Officer and principal accounting officer until a permanent successor is named.
Aditya J. Gandhi resigns as Vice President, Chief Accounting Officer, effective September 11, 2026
Daniel Ackerman, age 53, appointed Senior Vice President, Interim Chief Accounting Officer, effective September 11, 2026
Ackerman previously served as CAO from August 1, 2024 until June 8, 2026, and has been SVP, Finance for Aptar Pharma since June 2026
Ackerman will report to Vanessa Kanu, Executive Vice President and Chief Financial Officer
Insulet directors Timothy J. Scannell and Michael R. Minogue are stepping down from the board, effective September 3 and September 15, 2026, respectively. Scannell cited health reasons, and Minogue is leaving to focus on his candidacy for Governor of Massachusetts; the filing says neither departure stems from a disagreement with the company.
Timothy J. Scannell, who served 12 years on the board including 7 years as Chairman, steps down effective September 3, 2026, citing health reasons
Michael R. Minogue, who served 9 years, notified the company on September 8, 2026 and steps down effective September 15, 2026 to pursue a run for Governor of Massachusetts
The filing states neither director resigned due to a disagreement with the company on operations, policies or practices
Hawthorn Bancshares disclosed that Jonathan "Jon" Holtaway, a director of the company and Hawthorn Bank since 2019, died on September 4, 2026, at age 55. The company said it was informed on September 8 and issued a press release on September 10, which is filed as Exhibit 99.1. The filing does not describe any change to the company's operations or financial results.
Mr. Holtaway died on September 4, 2026, at age 55.
He had been a member of the Board of Directors since 2019.
The company was informed on September 8, 2026, and issued a press release on September 10, 2026.
Mr. Holtaway was president of Ategra Capital Management, LLC, which he founded in 2005.
Versus Systems appointed Brian Goldenberg as its Chief Financial Officer, Principal Financial Officer, and Principal Accounting Officer on September 8, 2026. CEO Luis Goldner will no longer serve as principal financial officer, so the CFO role now sits with Goldenberg, who previously held CFO positions at Trend Capital Management and Divisadero Street Capital Management.
Brian Goldenberg appointed CFO, principal financial officer and principal accounting officer on September 8, 2026
Luis Goldner, President and CEO, will no longer serve as principal financial officer
Goldenberg was CFO of Trend Capital Management, Boca Raton, Florida, from February 2018 to November 2023
From November 2023 to February 2026, Goldenberg was COO, chief compliance officer and CFO of Divisadero Street Capital Management, Miami, Florida
Candel Therapeutics expanded its Board from ten to eleven directors and appointed Martine Zimmermann, Pharm.D., as an independent director effective September 8, 2026. The company said her regulatory and quality expertise supports its planned Biologics License Application submission for aglatimagene besadenovec in the fourth quarter of 2026.
Board size increased from ten to eleven directors; Zimmermann appointed September 6, 2026, effective September 8, 2026
Zimmermann receives an option to purchase 64,000 shares of common stock, vesting in equal monthly installments over three years
Annual Board retainer of $40,000, paid quarterly in arrears and pro-rated for days served
Zimmermann is Executive Vice President at Inventiva S.A. and a director of Nasdaq-listed Ligand Pharmaceuticals since October 2023
SCYNEXIS said Chief Financial Officer Ivor Macleod retired effective September 9, 2026, and named Sanjay Subramanian as his successor, with an employment agreement effective the same day. Macleod will stay with the company through October 9, 2026 to support the transition. The filing contains no financial results or guidance, so the change is a leadership update rather than a measure of company performance.
Ivor Macleod ceased serving as CFO, principal financial officer and principal accounting officer effective September 9, 2026, and remains with the company through October 9, 2026.
Sanjay Subramanian's employment agreement is effective September 9, 2026, with an annual base salary of $500,000 and a discretionary annual bonus of up to 40% of base salary.
Subramanian received a stock option for 100,000 shares at $4.91, the September 9, 2026 closing price, vesting over four years.
Severance is nine months' base salary if terminated outside 12 months after a change of control, and 18 months' base salary if within that period.
Huntington Bancshares appointed Brantley J. Standridge as President of the Company and its bank subsidiary, effective September 8, 2026, taking the role from Chairman and CEO Stephen D. Steinour, who remains in his current positions. The filing also raises Standridge's pay targets effective September 15, 2026.
Brantley J. Standridge, 50, appointed President effective September 8, 2026; he previously served as Senior Executive Vice President and President of Consumer and Regional Banking since April 2023
Stephen D. Steinour continues as Chairman and Chief Executive Officer of the Company and CEO of The Huntington National Bank
Base salary increases from $850,000 to $1,000,000; annual incentive target rises from $1,487,500 to $1,850,000, pro-rated for 2026; long-term incentive target rises from $2,762,500 to $4,650,000, effective September 15, 2026
Village Farms International appointed Hamid Shekarchi as Interim Chief Financial Officer effective September 10, 2026, replacing Stephen Ruffini in that role. The company states that Ruffini's transition is not the result of any disagreement with management or the board, and he remains Company Secretary and takes on the role of Head of M&A.
Hamid Shekarchi, 41, was CFO of the company's Canadian Cannabis operations since February 1, 2024, and joined the Pure Sunfarms subsidiary in 2021.
Stephen Ruffini ceases to serve as CFO as of September 10, 2026, but stays on as Company Secretary, Head of M&A, advisor to the CEO and a full-time employee.
Shekarchi's interim CFO pay includes a C$567,000 annual base salary, a 50% target bonus, a 100,000 stock option grant and a one-time RSU award of 20% of base salary.
If Shekarchi is terminated without cause, the company will provide 12 months' notice by lump sum or continuance.
Mobileye's Board determined on September 3, 2026 that Chief Operating Officer Yaacov "Kobi" Ohayon will be designated the company's principal operating officer and an executive officer under Section 16 of the Securities Exchange Act. The filing says this reflects the scope of his existing responsibilities and does not change his duties, employment status, or compensation.
Board action dated September 3, 2026 designates Ohayon, 51, as principal operating officer
Ohayon has served as Chief Operating Officer since 2020 and with the company since 2017
Existing compensation arrangements were not modified; he signed the standard officers' indemnification agreement
Fortrea's board reinstated Jason Knoblauch as Chief Financial Officer on September 9, 2026, after a temporary restraining order that had kept him from the role was resolved through a settlement and mutual release. Director David Smith, who had served as interim CFO during the leave, stepped down from that role but remains on the board.
Board reinstated Jason Knoblauch as CFO and principal financial officer on September 9, 2026
Delaware Court of Chancery had issued a temporary restraining order on July 25, 2026 barring him from working as CFO
Company, Knoblauch and his former employer entered a settlement agreement and mutual release
David Smith stepped down as interim CFO but remains a board member
Pinnacle Financial Partners amended its letter agreement with Harold R. Carpenter, extending his non-compete and non-solicitation covenants and cooperation duties through March 31, 2027. In exchange, the company will accelerate a $1,000,000 installment to October 1, 2026 and pay an additional $500,000 on or after March 31, 2027, subject to repayment or forfeiture if he breaches the non-compete.
Amended letter agreement with Harold R. Carpenter dated September 9, 2026, extends covenants through March 31, 2027
Second installment of $1,000,000 accelerated from on or after January 1, 2027 to October 1, 2026
Additional $500,000 cash payment due on or after March 31, 2027, subject to clawback or forfeiture on breach
Mobileye said Executive Vice President of Business Development & Strategy Nimrod Nehushtan will move to a part-time role focused on corporate strategy, effective September 3, 2026. Nimrod Brickman, the current Vice President of Business Development, will continue to lead the company's business development activities, and Nehushtan's existing compensation arrangements have not been modified.
Nimrod Nehushtan's transition to a part-time corporate strategy role took effect September 3, 2026.
Nimrod Brickman, current Vice President of Business Development, will continue to lead business development.
Nehushtan's existing compensation arrangements have not been modified as of the filing date.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.